Their analytical testing detected significant levels of an unknown impurity that appears to result from a chemical reaction between tirzepatide and B12 molecules within the compounded solution
Exclusion criteria included the Concept ID for diagnoses of Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, Elevated HbA1C levels (6.5), and conditions that would increase fracture risk, including diagnoses for: Osteoporosis, Rheumatoid Arthritis, Chronic Kidney Disease, and Long-term Corticosteroid Use
Its ability to modulate appetite, enhance insulin sensitivity, mobilize fat, and increase energy use positions it as a promising therapeutic agent for obesity, type 2 diabetes mellitus, and related metabolic disorders
The patient can do as little or as much as he or she desires
These upstream mechanisms influence appetite regulation and metabolic flexibility